Neoleukin Therapeutics NLTX

$ 3.49 0.0%

Quarterly report 2024-Q3
added 11-18-2024

Neoleukin Therapeutics Balance Sheet 2011-2024 | NLTX

Annual Balance Sheet Neoleukin Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-146 M	-81.3 M	-141 M	-193 M	-142 M	-76.9 M	-52 M	-32.3 M	-39.5 M	-14.9 M	-8.72 M	-2 M	-
Long Term Debt	65 K	66 K	67 K	11.3 K	-	-	-	-	-	-	2.04 M	-	-
Long Term Debt Current	2.56 M	678 K	1.17 M	659 K	556 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	11.4 M	593 K	319 K	486 K	197 K	131 K	72.3 K	2.27 M	53.1 M	-
Total Current Liabilities	23 M	6.65 M	8.64 M	7.89 M	4.74 M	4.63 M	11 M	9.52 M	4.79 M	5.2 M	-	-	-
Total Liabilities	36.5 M	10.6 M	20.4 M	19.3 M	5.34 M	4.95 M	11.4 M	9.72 M	4.92 M	5.28 M	4.89 M	53.4 M	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-187 M	-151 M	-393 M	-333 M	-300 M	-230 M	-199 M	-148 M	-111 M	-89.4 M	-63.6 M	-51.6 M	-
Total Assets	223 M	109 M	163 M	211 M	147 M	77.6 M	110 M	154 M	113 M	41.4 M	15.6 M	2.34 M	-
Cash and Cash Equivalents	148 M	82 M	142 M	193 M	143 M	76.9 M	52 M	32.3 M	39.5 M	14.9 M	11 M	2 M	-
Book Value	186 M	98.6 M	143 M	191 M	142 M	72.7 M	98.9 M	145 M	108 M	36.1 M	10.8 M	-51.1 M	-
Total Shareholders Equity	186 M	-146 M	143 M	191 M	142 M	72.7 M	98.9 M	145 M	108 M	36.1 M	-65.7 M	-51.1 M	-

All numbers in USD currency

Quarterly Balance Sheet Neoleukin Therapeutics

	2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	39 K	53 K	65 K	5 K	6 K	7 K	233 K	9 K	10 K	66 K	67 K	68 K	68 K	122 K	108 K	108 K	108 K	108 K	146 K	146 K	146 K	146 K	6 K	6 K	6 K	6 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	26.7 M	24.8 M	36.5 M	14.4 M	14.4 M	17.1 M	21.6 M	20.9 M	20.3 M	19 M	20.4 M	21.1 M	20 M	21.1 M	19.3 M	19.3 M	19.3 M	19.3 M	5.34 M	5.34 M	5.34 M	5.34 M	4.95 M	4.95 M	4.95 M	4.95 M	11.4 M	11.4 M	11.4 M	11.4 M	9.72 M	9.72 M	9.72 M	9.72 M	4.92 M	4.92 M	4.92 M	4.92 M	5.28 M	5.28 M	5.28 M	5.28 M	7.48 M	7.48 M	7.48 M	7.48 M	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-243 M	-223 M	-187 M	-472 M	-467 M	-465 M	-451 M	-438 M	-425 M	-409 M	-393 M	-378 M	-363 M	-348 M	-333 M	-333 M	-333 M	-333 M	-300 M	-300 M	-300 M	-300 M	-230 M	-230 M	-230 M	-230 M	-199 M	-199 M	-199 M	-199 M	-148 M	-148 M	-148 M	-148 M	-111 M	-111 M	-111 M	-111 M	-89.4 M	-89.4 M	-89.4 M	-89.4 M	-65.7 M	-65.7 M	-65.7 M	-	-	-	-	-	-	-	-	-
Total Assets	164 M	180 M	223 M	89.6 M	94 M	98.5 M	116 M	127 M	137 M	149 M	163 M	176 M	187 M	200 M	211 M	211 M	211 M	211 M	147 M	147 M	147 M	147 M	77.6 M	77.6 M	77.6 M	77.6 M	110 M	110 M	110 M	110 M	154 M	154 M	154 M	154 M	113 M	113 M	113 M	113 M	41.4 M	41.4 M	41.4 M	41.4 M	15.6 M	15.6 M	15.6 M	15.6 M	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	66.6 M	111 M	148 M	45.6 M	59 M	35.5 M	37.9 M	41.2 M	78.4 M	129 M	142 M	156 M	165 M	178 M	193 M	193 M	193 M	193 M	143 M	143 M	143 M	143 M	76.9 M	76.9 M	76.9 M	76.9 M	52 M	52 M	52 M	52 M	32.3 M	32.3 M	32.3 M	32.3 M	39.5 M	39.5 M	39.5 M	39.5 M	14.9 M	14.9 M	14.9 M	14.9 M	11 M	11 M	11 M	11 M	2 M	-	-	-	9.24 M	-	-	-
Book Value	137 M	155 M	186 M	75.2 M	79.6 M	81.4 M	94.3 M	106 M	117 M	130 M	143 M	155 M	167 M	179 M	191 M	191 M	191 M	191 M	142 M	142 M	142 M	142 M	72.7 M	72.7 M	72.7 M	72.7 M	98.9 M	98.9 M	98.9 M	98.9 M	145 M	145 M	145 M	145 M	108 M	108 M	108 M	108 M	36.1 M	36.1 M	36.1 M	36.1 M	8.17 M	8.17 M	8.17 M	8.17 M	-	-	-	-	-	-	-	-
Total Shareholders Equity	137 M	155 M	186 M	-183 M	-169 M	81.4 M	94.3 M	106 M	117 M	130 M	143 M	155 M	167 M	179 M	191 M	191 M	191 M	191 M	142 M	142 M	142 M	142 M	72.7 M	72.7 M	72.7 M	72.7 M	98.9 M	98.9 M	98.9 M	98.9 M	145 M	145 M	145 M	145 M	108 M	108 M	108 M	108 M	36.1 M	36.1 M	36.1 M	36.1 M	-65.7 M	-65.7 M	-65.7 M	-65.7 M	-51.1 M	-	-	-	-39.3 M	-	-	-

All numbers in USD currency